Uncertain Times: New Lockdowns, Ukraine Challenge Chinese Pharma

 
• By Brian Yang

As residents of China's largest city brace for a possible prolonged lockdown, the gathering COVID-19 outbreak is set to cause some pharma disruption in the country, while broader geopolitical factors including Ukraine are hindering the industry's global ambitions. 

Beijing residents waiting in line to get PCR Testing on March 21 morning.
BEIJING RESIDENTS WAITING TO GET PCR TESTING ON MARCH 21, 2022 • Source: Brian Yang/Pink Sheet

More from Distribution/Supply Chain

More from Compliance